Morphosys raises forecasts on Janssen Biotech milestone payment

FRANKFURT, Oct 23 (Reuters) - German biotech company Morphosys raised its earnings forecast for 2014, citing a milestone payment from Janssen Biotech as well as a partial shift of development costs to 2015.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.